Verapamil
"Verapamil" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A calcium channel blocker that is a class IV anti-arrhythmia agent.
Descriptor ID |
D014700
|
MeSH Number(s) |
D02.092.471.683.953
|
Concept/Terms |
Lekoptin- Lekoptin
- Sandoz Brand of Verapamil
- Verapamil Sandoz Brand
|
Below are MeSH descriptors whose meaning is more general than "Verapamil".
Below are MeSH descriptors whose meaning is more specific than "Verapamil".
This graph shows the total number of publications written about "Verapamil" by people in UAMS Profiles by year, and whether "Verapamil" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2020 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2017 | 1 | 0 | 1 |
2013 | 1 | 0 | 1 |
2012 | 0 | 1 | 1 |
2011 | 0 | 1 | 1 |
2009 | 1 | 0 | 1 |
2004 | 0 | 1 | 1 |
1999 | 0 | 1 | 1 |
1996 | 1 | 0 | 1 |
1994 | 0 | 1 | 1 |
1990 | 1 | 1 | 2 |
1989 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Verapamil" by people in Profiles over the past ten years.
-
Mao G, Gigliotti MJ, Esplin N, Sexton K. The clinical impact and safety profile of high-dose intra-arterial verapamil treatment for cerebral vasospasm following aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg. 2021 Mar; 202:106546.
-
Abumoussa A, Flores A, Ho J, Niethammer M, Sasaki-Adams D, Lee YZ. Computational methods for visualizing and measuring verapamil efficacy for cerebral vasospasm. Sci Rep. 2020 11 02; 10(1):18780.
-
Dang NL, Hughes TB, Miller GP, Swamidass SJ. Computationally Assessing the Bioactivation of Drugs by N-Dealkylation. Chem Res Toxicol. 2018 02 19; 31(2):68-80.
-
Abdelaziz HK, Elkilany W, Khalid S, Sabet S, Saad M. Efficacy and safety of intracoronary verapamil versus sodium nitroprusside for the prevention of microvascular obstruction during primary percutaneous coronary intervention for ST-segment elevation myocardial infarction. Coron Artery Dis. 2017 Jan; 28(1):11-16.